Cart
sales@molnova.com
Ginkgolic acid C13:0
CAS No. 20261-38-5
Ginkgolic acid C13:0( 6-n-Tridecylsalicylic acid | 6-n-TDSCA | HY-N0078 | AR-1E2490 )
Catalog No. M18208 CAS No. 20261-38-5
Ginkgolic acid C13: exhibits the highest α-glucosidase inhibitory activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 33 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 152 | In Stock |
|
| 50MG | 230 | In Stock |
|
| 100MG | 341 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGinkgolic acid C13:0
-
NoteResearch use only, not for human use.
-
Brief DescriptionGinkgolic acid C13: exhibits the highest α-glucosidase inhibitory activity.
-
DescriptionGinkgoneolic acid, also known as 6-n-Tridecylsalicylic acid, is an HIV protease inhibitor and indirect PP2C activator found in Ginkgo. It inhibits fatty acid synthase, induce apoptosis in cancer cells, and suppresses growth of Staphylococcus, Escherichia and Bacillus.
-
In Vitro——
-
In Vivo——
-
Synonyms6-n-Tridecylsalicylic acid | 6-n-TDSCA | HY-N0078 | AR-1E2490
-
PathwayOthers
-
TargetOther Targets
-
Recptorα-glucosidase
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number20261-38-5
-
Formula Weight320.47
-
Molecular FormulaC20H32O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (312.04 mM)
-
SMILESCCCCCCCCCCCCCC1=C(C(=CC=C1)O)C(=O)O
-
Chemical Name2-hydroxy-6-tridecylbenzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
IMAB027
IMAB027 (ASP1650) is a specific monoclonal antibody targeting CLDN6 (Claudin 6), a membrane protein of tight junctions aberrantly overexpressed in multiple human cancers, notably ovarian cancers.
-
N-[35-bis(trifluoroM...
N-[35-bis(trifluoroMethyl)phenyl]-N'-[(9R)-6'-Methoxycinchonan-9-yl]- Thiourea is a chemical compound.
-
Buddlejasaponin IVb
Buddlejasaponin IVb(200 uM) can shorten thrombin time (TT) by 20.6 %, suggests that it has hemostasis efficacy.
